Jafron Biomedical Co.,Ltd. (SZSE: 300529)
Health Care · Health Care Equipment & Supplies · CN
CN¥15.76
-2.78% today · -34.7% 1Y
Jafron Biomedical Co.,Ltd. (SZSE: 300529) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $1.82B and employs 2,200 people.
Over the last twelve months the share price has lost 34.7%, trading between 14.73 and 24.66.
Tweenvest scores Jafron Biomedical Co.,Ltd. across four factors: quality 75/100, value 71/100, growth 0/100, dividend 29/100. Its strongest factor is quality.
300529 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.82B
- Revenue (TTM)
- $281.16M
- P/E
- 23.41
- EPS
- 0.67
- Dividend yield
- 3.30%
- Beta (5Y)
- 0.33
- 52-week high
- CN¥24.66
- 52-week low
- CN¥14.73
- Avg volume (3M)
- —
- Shares outstanding
- 774.36M
- Employees
- 2,200
- Next earnings
- —
About Jafron Biomedical Co.,Ltd.
Jafron Biomedical Co.,Ltd. engages in the research and development, production, and sale of blood purification products for hemadsorption field worldwide. The company offers therapies for kidney, liver, and critical diseases, as well as poisoning. It also provides HA series disposable hemoperfusion cartridge; BS series disposable plasma bilirubin perfusion adsorption column; blood purification machine; and other products, such as JM hemodialyzer, DNA230, disinfectant, hemodialysis concentrate, resin bandage, online hemodialysis B powder bag/bucket, PGA absorbable suture with needle, syringe and infusion pumps. The company was founded in 1989 and is based in Zhuhai, China.
- ISIN
- CNE100002995
- Founded
- 1989
- Listed since
- Aug 2, 2016
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.83B | $116.64 | +2.19% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $133.83B | $378.81 | +1.19% |
| Stryker CorporationNYSE: SYK | $126.37B | $329.45 | +0.53% |
| Medtronic plcNYSE: MDT | $119.49B | $93.35 | +1.14% |
| EssilorLuxottica Société anonymeENXTPA: EL | $87.56B | €163.20 | +1.24% |
| Boston Scientific CorporationNYSE: BSX | $73.00B | $50.37 | +2.03% |
| HOYA CorporationTSE: 7741 | $52.38B | ¥24,895.00 | -1.37% |
| Becton, Dickinson and CompanyNYSE: BDX | $52.30B | $192.00 | +2.33% |
Figures last refreshed Aug 18, 2026.